IHE & IICC announce LAW Virtual Connectathon 2015 for testing of LAW 1.4 Profile
Companies who successfully complete the LAW Virtual Connectathon 2015 will be showcased in a live demonstration at the IICC booth at the AACC 2015 Annual Conference in Atlanta.
The event will take place entirely online, July 6th through July 10th. This is a unique opportunity to test your LAW implementation remotely, saving you valuable travel time and money.
The purpose of the new IHE LAW Profile is to improve interoperability between IVD testing systems and health informatics systems by reducing complexity and variability in the exchange of information related to patient and QC test orders and to the result thereof. IHE LAW 1.4 was released on March 16, 2015 and available for download at:
Registration should be made June 10th through Gazelle Test Management available at:
The fee for participating in the LAW Virtual Connectathon 2015 is €4,000.00
To learn more about Gazelle and the Connectathon, please use the following on-line introduction materials provided by IHE:
IHE has also established a Google Group for communications about the LAW Virtual Connectathon. Please use the following link to join the group:
The next live IHE NA Connectathon 2016 event will take place Jan 25th through Jan 29th at the Cleveland Convention Center in Cleveland Ohio. The following vendors have already committed to participate: Abbott, Beckman Coulter, bioMerieux, Clinisys, Data Innovations, Orchard Software, Roche, and Siemens. For more information go to: http://www.iheusa.org/events.aspx
The IVD Industry Connectivity Consortium (IICC) is a global, nonprofit organization dedicated to creating and encouraging adoption of a unified connectivity standard to reduce the cost and variability of data exchange between IVD devices and healthcare informatics. This will improve healthcare efficiency and patient care. Member organizations include Abbott Diagnostics, Beckman Coulter, Becton Dickinson, bioMérieux, Data Innovations, Orchard Software, Ortho Clinical Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics, and Systelab Technologies, S.A.